|Original language||English (US)|
|Journal||Journal of the European Academy of Dermatology and Venereology|
|State||Accepted/In press - 2021|
ASJC Scopus subject areas
- Infectious Diseases
Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib. / Thyssen, J. P.; Lio, P.; Ball, S.; Pierce, E.; Sun, L.; Chen, Y.; Tan, J. K.L.; Augustin, M.In: Journal of the European Academy of Dermatology and Venereology, 2021.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib
AU - Thyssen, J. P.
AU - Lio, P.
AU - Ball, S.
AU - Pierce, E.
AU - Sun, L.
AU - Chen, Y.
AU - Tan, J. K.L.
AU - Augustin, M.
N1 - Funding Information: This study was sponsored by Eli Lilly and Company, under licence from Incyte Corporation. Funding Information: JPT has received compensation as a speaker, advisor or consultant for, or has received grant support from AbbVie, Eli Lilly and Company, LEO Pharma, Pfizer, Regeneron and Sanofi Genzyme. PL has received compensation as a speaker or advisor for, or received grant support from AbbVie, AOBiome, Dermavant, Eli Lilly and Company, Galderma, Johnson & Johnson, LEO Pharma, L’Oreal, Micreos, Pfizer, Regeneron/Sanofi Genzyme, has received royalties from/has a licence with, and has planned patent with Theraplex AIM, and has stock options with Altus Labs and Micreos. SB, EP, LS and YC are employees and shareholders of Eli Lilly and Company. JKLT has received compensation as a consultant or advisor for, and travel support from Eli Lilly and Company. MA has received compensation as a consultant or speaker for, and has received grant support from AbbVie, Almirall, Beiersdorf, Eli Lilly and Company, Galderma, Incyte, LEO Pharma, Menlo, MSD, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme and Trevi.
PY - 2021
Y1 - 2021
UR - http://www.scopus.com/inward/record.url?scp=85116024986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116024986&partnerID=8YFLogxK
U2 - 10.1111/jdv.17704
DO - 10.1111/jdv.17704
M3 - Letter
C2 - 34553429
AN - SCOPUS:85116024986
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
SN - 0926-9959